Inventor · disambiguated record
Edward Holson
Also filed as: HOLSON EDWARD · HOLSON EDWARD B
46 granted patents·6 pending applications·371 citations·filing 1996–2024
97Inventor score
Files withBROAD INST INC23CASTRO ALFREDO C5AMATHUS THERAPEUTICS INC3INFINITY PHARMACEUTICALS INC3MASSACHUSETTS GEN HOSPITAL3
Top patents by PatentIndex Score
52 records- 0196US6166037APyrrolidine and piperidine modulators of chemokine receptor activityMERCK & CO INC·Filed 1998·Granted Dec 26, 2000·171 cites·25 claims
- 0294US5750549ACycloalkyl tachykinin receptor antagonistsMERCK & CO INC·Filed 1996·Granted May 12, 1998·89 cites·30 claims
- 0393US10662199B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2017·Granted May 26, 2020·3 cites·39 claims
- 0492US9890172B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2016·Granted Feb 13, 2018·10 cites·28 claims
- 0591US9447030B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2013·Granted Sep 20, 2016·13 cites·22 claims
- 0691US9365498B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2013·Granted Jun 14, 2016·13 cites·22 claims
- 0788US10137122B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2015·Granted Nov 27, 2018·8 cites·66 claims
- 0887US9096594B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2013·Granted Aug 4, 2015·9 cites·22 claims
- 0986US7842815B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2006·Granted Nov 30, 2010·5 cites·3 claims
- 1085US7851637B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Dec 14, 2010·13 cites·17 claims
- 1184US10793538B2Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitorsBROAD INST INC·Filed 2018·Granted Oct 6, 2020·3 cites·20 claims
- 1283US11052080B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2018·Granted Jul 6, 2021·3 cites·31 claims
- 1381US11572368B2Inhibitors of histone deacetylaseMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Feb 7, 2023·1 cites·38 claims
- 1481US11498896B2Dopamine D2 receptor ligandsBROAD INST INC·Filed 2020·Granted Nov 15, 2022·1 cites·32 claims
- 1581US11203601B2Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereofBROAD INST INC·Filed 2018·Granted Dec 21, 2021·2 cites·41 claims
- 1681US9790184B2Inhibitors of histone deacetylaseMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Oct 17, 2017·6 cites·25 claims
- 1781US7947670B2Ansamycin formulations and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2007·Granted May 24, 2011·3 cites·20 claims
- 1880US10633336B2Dopamine D2 receptor ligandsBROAD INST INC·Filed 2015·Granted Apr 28, 2020·2 cites·22 claims
- 1979US9914717B2Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitorsBROAD INST INC·Filed 2013·Granted Mar 13, 2018·5 cites·28 claims
- 2077US10752588B2Dopamine D2 receptor ligandsBROAD INST INC·Filed 2015·Granted Aug 25, 2020·2 cites·28 claims
- 2176US11377423B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2017·Granted Jul 5, 2022·2 cites·91 claims
- 2275US9745613B2Compounds, substrates and methods related to histone deacetylasesBROAD INST INC·Filed 2015·Granted Aug 29, 2017·1 cites·3 claims
- 2374US12428373B2Dopamine D2 receptor ligandsBROAD INST INC·Filed 2022·Granted Sep 30, 2025·0 cites·37 claims
- 2473US8461191B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2010·Granted Jun 11, 2013·1 cites·38 claims
- 2572US12419885B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2021·Granted Sep 23, 2025·0 cites·42 claims
- 2672US9265764B2Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disordersHAGGARTY STEPHEN J·Filed 2010·Granted Feb 23, 2016·3 cites·18 claims
- 2771US9856509B2Fluorescent substrates for determining lysine modifying enzyme activityBROAD INST INC·Filed 2014·Granted Jan 2, 2018·1 cites·29 claims
- 2869US8729130B2Methods of using novel solid forms of tacedinalineHOLSON EDWARD·Filed 2012·Granted May 20, 2014·1 cites·7 claims
- 2968US2025255839A1Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancerKDAC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3065US8357676B2Ansamycin formulations and methods of use thereofINFINITY DISCOVERY INC·Filed 2008·Granted Jan 22, 2013·0 cites·22 claims
- 3165US8283343B2Ansamycin formulations and methods of use thereofAUSTAD BRIAN C·Filed 2008·Granted Oct 9, 2012·0 cites·13 claims
- 3264US10626438B2Fluorescent substrates for determining lysine modifying enzyme activityBROAD INST INC·Filed 2017·Granted Apr 21, 2020·0 cites·22 claims
- 3364US9266822B2Solid forms of tacedinalineBROAD INST INC·Filed 2014·Granted Feb 23, 2016·0 cites·4 claims
- 3463US10125387B2Compounds, substrates and methods related to histone deacetylasesBROAD INST INC·Filed 2017·Granted Nov 13, 2018·0 cites·20 claims
- 3562US12486289B2Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereofBROAD INST INC·Filed 2021·Granted Dec 2, 2025·0 cites·31 claims
- 3661US9320751B2Modified saponins for the treatment of fungal infectionsGEN HOSPITAL CORP·Filed 2015·Granted Apr 26, 2016·0 cites·6 claims
- 3759US7928244B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY DISCOVERY INC·Filed 2007·Granted Apr 19, 2011·0 cites·37 claims
- 3858US8691875B2Solid forms of tacedinalineHOLSON EDWARD·Filed 2012·Granted Apr 8, 2014·0 cites·4 claims
- 3956US9629865B2Modified saponins for the treatment of fungal infectionsMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Apr 25, 2017·0 cites·5 claims
- 4056US8178690B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2011·Granted May 15, 2012·0 cites·15 claims
- 4155US2023218632A1Cyclic sulfonamide derivatives as trap1 modulators and uses thereofAMATHUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4255US2023174523A1Benzenesulfonamide derivatives as trap1 modulators and uses thereofAMATHUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4355US2023159509A1Pyridinesulfonamide derivatives as trap1 modulators and uses thereofAMATHUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4454US8987217B2Modified saponins for the treatment of fungal infectionsMYLONAKIS ELEFTHERIOS·Filed 2011·Granted Mar 24, 2015·0 cites·11 claims
- 4554US8609706B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2012·Granted Dec 17, 2013·0 cites·14 claims
- 4654US7745464B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2006·Granted Jun 29, 2010·0 cites·18 claims
- 4752US2012101147A1Inhibition of hdac2 to promote memoryTSAI LI-HUEI·Filed 2009·Application pending·0 cites
- 4851US12128018B2Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancerKDAC THERAPEUTICS INC·Filed 2019·Granted Oct 29, 2024·0 cites·34 claims
- 4950US8841346B2Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disordersTSAI LI-HUEI·Filed 2012·Granted Sep 23, 2014·0 cites·16 claims
- 5046US8563615B2Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disordersTSAI LI-HUEI·Filed 2010·Granted Oct 22, 2013·0 cites·10 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Edward Holson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →